Video

Dr Jeffrey Patton on Setting Standards of Care Through OneOncology’s Clinical Pathways Program

Representatives across 12 disease groups make up a council that sets clinical recommendations for oncology care and those decisions are being pushed out in the electronic medical record for decision support at the point of care, said Jeffrey Patton, MD, CEO, OneOncology, and executive chairman of the board, Tennessee Oncology. Patton will lead off OneOncology's Physician Leadership Conference, which runs November 11-13 in Nashville.

Representatives across 12 disease groups make up a council that sets clinical recommendations for oncology care and those decisions are being pushed out in the electronic medical record for decision support at the point of care, said Jeffrey Patton, MD, CEO, OneOncology, and executive chairman of the board, Tennessee Oncology. Patton will lead off OneOncology's Physician Leadership Conference, which runs November 11-13 in Nashville.

Transcript

What is the role of disease groups in the OneOncology clinical pathways program? How do member practices of OneOncology work with these clinical pathways day to day?

At OneOncology, we have a clinical leadership forum called One Council—everything's “one” with us. One Council is really a Senate-based model where we have representatives from each practice make clinical decisions and clinical recommendations. Within that group, we have 12 disease groups, where we have thought leaders or folks interested in specific disease discuss and set our standard of care in those disease groups. And then we're developing a pathway to tool with Flatiron Health and called Flatiron Assist, where those recommendations are written into the electronic medical record, so you don't have to go outside of the electronic medical record to get that decision support tool. And it really is decision support at the point of care.

Related Videos
Justin Oldham, MD, MS, an expert on IPF
Dr Bonnie Qin
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
dr carol regueiro
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo